Tianxing Healthcare (01609) announced interim results, net profit of 27.402 million yuan, a year-on-year decrease of 26.1%

According to the Zhitong Finance App, Tianxing Healthcare (01609) announced its 2026 interim results, with revenue of about 163 million yuan, up 21.6% year on year; net profit of 27.402 million yuan, down 26.1% year on year; adjusted profit of 488.97 million yuan, up 24.3% year on year; basic profit per share of 0.57 yuan.

According to the announcement, revenue growth is mainly due to the company's accelerated international market expansion strategy, and this move has significantly increased overseas market coverage and business scale. Overseas sales revenue during the period was approximately RMB 406.98 million, an increase of 70.6% over the same period in 2025. Overseas revenue increased as a share of total revenue to 24.9%.